Phospholipase A2 is activated in the kidney, but not in the liver during ischemia-reperfusion.
Yoshiaki Terao(Nagasaki University), Koji Sumikawa(Sasebo City General Hospital), S Haseba, Shinichi Goto, Harumasa Nakamura(Nagasaki University), Hiroaki Morooka(Nagasaki University), Osamu Shibata(University of Nagasaki)
PubMed
June 1, 1997
Cited by 9
Related Papers
Glutaredoxin Exerts an Antiapoptotic Effect by Regulating the Redox State of Akt
|Journal of Biological Chemistry|2003|316
Symptoms of Spinal Stenosis Do Not Improve After Epidural Steroid Injection
|Clinical Journal of Pain|1998|213
Effects of Sevoflurane with and without Nitrous Oxide on Human Cerebral Circulation
|Anesthesiology|1996|148
μ-Opioid Receptor Forms a Functional Heterodimer With Cannabinoid CB1 Receptor: Electrophysiological and FRET Assay Analysis
|Journal of Pharmacological Sciences|2008|146
Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial
|The Lancet Diabetes & Endocrinology|2023|116